Chelsea C Hays1, Zvinka Z Zlatar2, M J Meloy3, Mark W Bondi4, Paul E Gilbert5, Thomas T Liu6, Jonathan L Helm5, Christina E Wierenga7. 1. VA San Diego Healthcare System, 3350 La Jolla Village Dr., San Diego, 92161, USA; SDSU/UC San Diego Joint Doctoral Program in Clinical Psychology, 6363 Alvarado Court, Suite 103, San Diego, CA, 92120, USA. 2. Department of Psychiatry, UC San Diego, 9500 Gilman Dr., La Jolla, CA, 92093, USA; SDSU/UC San Diego Joint Doctoral Program in Clinical Psychology, 6363 Alvarado Court, Suite 103, San Diego, CA, 92120, USA. 3. VA San Diego Healthcare System, 3350 La Jolla Village Dr., San Diego, 92161, USA; Department of Psychiatry, UC San Diego, 9500 Gilman Dr., La Jolla, CA, 92093, USA. 4. VA San Diego Healthcare System, 3350 La Jolla Village Dr., San Diego, 92161, USA; Department of Psychiatry, UC San Diego, 9500 Gilman Dr., La Jolla, CA, 92093, USA; SDSU/UC San Diego Joint Doctoral Program in Clinical Psychology, 6363 Alvarado Court, Suite 103, San Diego, CA, 92120, USA. 5. SDSU/UC San Diego Joint Doctoral Program in Clinical Psychology, 6363 Alvarado Court, Suite 103, San Diego, CA, 92120, USA; Department of Psychology, San Diego State University, 5500 Campanile Drive, San Diego, CA, 92182, USA. 6. Department of Radiology, UC San Diego, 9500 Gilman Dr., La Jolla, CA, 92093, USA. 7. VA San Diego Healthcare System, 3350 La Jolla Village Dr., San Diego, 92161, USA; Department of Psychiatry, UC San Diego, 9500 Gilman Dr., La Jolla, CA, 92093, USA; SDSU/UC San Diego Joint Doctoral Program in Clinical Psychology, 6363 Alvarado Court, Suite 103, San Diego, CA, 92120, USA. Electronic address: cwierenga@ucsd.edu.
Abstract
OBJECTIVE: The ε4 allele of the apolipoprotein E (APOE) gene increases risk for cognitive decline in normal and pathologic aging. However, precisely how APOE ε4 exerts its negative impact on cognition is poorly understood. The present study aimed to determine whether APOE genotype (ε4+ vs. ε4-) modifies the interaction of medial temporal lobe (MTL) resting cerebral blood flow (CBF) and brain structure (cortical thickness [CT], volume [Vo]) on verbal memory performance. METHODS: Multiple linear regression models were employed to investigate relationships between APOE genotype, arterial spin labeling MRI-measured CBF and FreeSurfer-based CT and Vo in four MTL regions of interest (left and right entorhinal cortex and hippocampus), and verbal memory performance among a sample of 117 cognitively normal older adults (41 ε4+, 76 ε4-) between the ages of 64 and 89 (mean age = 73). RESULTS: Results indicated that APOE genotype modified the interaction of CBF and CT on memory in the left entorhinal cortex, such that the relationship between entorhinal CBF and memory was negative (lower CBF was associated with better memory) in non-carriers with higher entorhinal CT, positive (higher CBF was associated with better memory) in non-carriers with lower entorhinal CT, and negative (higher CBF was associated with worse memory) in ε4 carriers with lower entorhinal CT. CONCLUSIONS: Findings suggest that older adult APOE ε4 carriers may experience vascular dysregulation and concomitant morphological alterations in the MTL that interact to negatively affect memory even in the absence overt clinical symptoms, providing potential insight into the mechanistic link between APOE ε4 and detriments in cognition. Moreover, findings suggest a distinct multimodal neural signature in ε4 carriers (higher CBF and lower CT in the entorhinal cortex) that could aid in the identification of candidates for future clinical trials aimed at preventing or slowing cognitive decline. Differential findings with respect to ε4 carriers and non-carriers are discussed in the context of neurovascular compensation. Published by Elsevier Inc.
OBJECTIVE: The ε4 allele of the apolipoprotein E (APOE) gene increases risk for cognitive decline in normal and pathologic aging. However, precisely how APOE ε4 exerts its negative impact on cognition is poorly understood. The present study aimed to determine whether APOE genotype (ε4+ vs. ε4-) modifies the interaction of medial temporal lobe (MTL) resting cerebral blood flow (CBF) and brain structure (cortical thickness [CT], volume [Vo]) on verbal memory performance. METHODS: Multiple linear regression models were employed to investigate relationships between APOE genotype, arterial spin labeling MRI-measured CBF and FreeSurfer-based CT and Vo in four MTL regions of interest (left and right entorhinal cortex and hippocampus), and verbal memory performance among a sample of 117 cognitively normal older adults (41 ε4+, 76 ε4-) between the ages of 64 and 89 (mean age = 73). RESULTS: Results indicated that APOE genotype modified the interaction of CBF and CT on memory in the left entorhinal cortex, such that the relationship between entorhinal CBF and memory was negative (lower CBF was associated with better memory) in non-carriers with higher entorhinal CT, positive (higher CBF was associated with better memory) in non-carriers with lower entorhinal CT, and negative (higher CBF was associated with worse memory) in ε4 carriers with lower entorhinal CT. CONCLUSIONS: Findings suggest that older adult APOE ε4 carriers may experience vascular dysregulation and concomitant morphological alterations in the MTL that interact to negatively affect memory even in the absence overt clinical symptoms, providing potential insight into the mechanistic link between APOE ε4 and detriments in cognition. Moreover, findings suggest a distinct multimodal neural signature in ε4 carriers (higher CBF and lower CT in the entorhinal cortex) that could aid in the identification of candidates for future clinical trials aimed at preventing or slowing cognitive decline. Differential findings with respect to ε4 carriers and non-carriers are discussed in the context of neurovascular compensation. Published by Elsevier Inc.
Authors: Bruce Fischl; David H Salat; Evelina Busa; Marilyn Albert; Megan Dieterich; Christian Haselgrove; Andre van der Kouwe; Ron Killiany; David Kennedy; Shuna Klaveness; Albert Montillo; Nikos Makris; Bruce Rosen; Anders M Dale Journal: Neuron Date: 2002-01-31 Impact factor: 17.173
Authors: Simona De Blasi; Alberto Montesanto; Cinzia Martino; Serena Dato; Francesco De Rango; Amalia C Bruni; Vincenzo Mari; Emidio Feraco; Giuseppe Passarino Journal: Exp Gerontol Date: 2008-11-24 Impact factor: 4.032
Authors: Maheen M Adamson; Kelly M Landy; Susan Duong; Sabrina Fox-Bosetti; J Wesson Ashford; Greer M Murphy; Michael Weiner; Joy L Taylor Journal: Neurobiol Aging Date: 2008-08-29 Impact factor: 4.673
Authors: Debby Tsuang; James B Leverenz; Oscar L Lopez; Ronald L Hamilton; David A Bennett; Julie A Schneider; Aron S Buchman; Eric B Larson; Paul K Crane; Jeffrey A Kaye; Patricia Kramer; Randy Woltjer; John Q Trojanowski; Daniel Weintraub; Alice S Chen-Plotkin; David J Irwin; Jacqueline Rick; Gerard D Schellenberg; G Stennis Watson; Walter Kukull; Peter T Nelson; Gregory A Jicha; Janna H Neltner; Doug Galasko; Eliezer Masliah; Joseph F Quinn; Kathryn A Chung; Dora Yearout; Ignacio F Mata; Jia Y Wan; Karen L Edwards; Thomas J Montine; Cyrus P Zabetian Journal: JAMA Neurol Date: 2013-02 Impact factor: 18.302
Authors: Christina E Wierenga; Lindsay R Clark; Sheena I Dev; David D Shin; Sarah M Jurick; Robert A Rissman; Thomas T Liu; Mark W Bondi Journal: J Alzheimers Dis Date: 2013 Impact factor: 4.472
Authors: Weiying Dai; Oscar L Lopez; Owen T Carmichael; James T Becker; Lewis H Kuller; H Michael Gach Journal: Radiology Date: 2009-01-21 Impact factor: 11.105
Authors: Chelsea C Hays; Zvinka Z Zlatar; M J Meloy; Jessica Osuna; Thomas T Liu; Douglas R Galasko; Christina E Wierenga Journal: J Alzheimers Dis Date: 2020 Impact factor: 4.472
Authors: Kelsey R Thomas; Jessica R Osuna; Alexandra J Weigand; Emily C Edmonds; Alexandra L Clark; Sophia Holmqvist; Isabel H Cota; Christina E Wierenga; Mark W Bondi; Katherine J Bangen Journal: J Cereb Blood Flow Metab Date: 2020-07-02 Impact factor: 6.200
Authors: Chelsea C Hays; Zvinka Z Zlatar; M J Meloy; Mark W Bondi; Paul E Gilbert; Thomas Liu; Jonathan L Helm; Christina E Wierenga Journal: Brain Imaging Behav Date: 2020-04 Impact factor: 3.978
Authors: Lok-Kin Yeung; Christiane Hale; Batool Rizvi; Kay Igwe; Richard P Sloan; Lawrence S Honig; Scott A Small; Adam M Brickman Journal: Neurobiol Aging Date: 2020-11-02 Impact factor: 4.673
Authors: Molly Memel; Adam M Staffaroni; Yann Cobigo; Kaitlin B Casaletto; Corrina Fonseca; Brianne M Bettcher; Michael A Yassa; Fanny M Elahi; Amy Wolf; Howard J Rosen; Joel H Kramer Journal: Hippocampus Date: 2021-04-09 Impact factor: 3.753
Authors: Katherine J Bangen; Kelsey R Thomas; Danielle L Sanchez; Emily C Edmonds; Alexandra J Weigand; Lisa Delano-Wood; Mark W Bondi Journal: J Alzheimers Dis Date: 2021 Impact factor: 4.160
Authors: Cassandra C Soo; Meagan T Farrell; Stephen Tollman; Lisa Berkman; Almut Nebel; Michèle Ramsay Journal: Front Genet Date: 2021-10-14 Impact factor: 4.772
Authors: Ai-Ling Lin; Ishita Parikh; Lucille M Yanckello; Renee S White; Anika M S Hartz; Chase E Taylor; Scott D McCulloch; Scott W Thalman; Mengfan Xia; Katie McCarty; Margo Ubele; Elizabeth Head; Fahmeed Hyder; Basavaraju G Sanganahalli Journal: Neurobiol Dis Date: 2020-03-12 Impact factor: 7.046
Authors: Danielle L Sanchez; Kelsey R Thomas; Emily C Edmonds; Mark W Bondi; Katherine J Bangen Journal: J Alzheimers Dis Date: 2020 Impact factor: 4.160